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ABSTRACT 
Considering the global popularity and also the various biological and medicinal properties of 
saffron, this study was conducted to assess the influence of its aqueous extracts administration 
on blood pressure, pressure-rate product (PRP) and electrocardiogram (ECG) indices of rat. 
Animals were divided to control (CTL), SAF50, SAF100, and SAF200 groups that orally re-
ceived tap water, aqueous extracts of saffron 50, 100 and 200 mg/kg/day respectively for sev-
en days. On day 8, data were recorded.  
Different doses of saffron had no significant effect on blood pressure and also PRP. Higher 
dose (200 mg/kg) of saffron significantly increased the PR interval, P duration, QT interval 
(p<0.01), QRS interval, QTcn (normalized corrected QT) (p<0.001), and JT interval (p<0.05) 
of ECG compared to the CTL group. In addition, the two other doses only significantly pro-
longed the QT, QTcn and JT intervals of ECG versus the CTL group. The SAF200 group also 
showed a notable increase in RR interval which only was significant versus to the SAF50. 
There was no significant difference among ST height and T amplitude ranges of different 
groups.  
The results suggest that high dose of saffron definitely slows the electrical conduction veloci-
ty in both atrium and ventricle. 
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INTRODUCTION 
The traditional consumption of saffron 
as a seasoning for some foods and also for 
medicinal purposes in the west and east so-
cieties is well known. In recent years, many 
studies reported some pharmacological and 
therapeutical aspects of saffron such as its 
protective effects on heart (Sachdeva et al., 
2012; Joukar et al., 2010), brain (Ghadr-
doost et al., 2011; Hosseinzadeh et al., 
2012) and kidney (Ajami et al., 2010) 
whenever these organs encountered to the 
stressful conditions. In vitro studies showed 
stimulatory effect of saffron on IFN-γ and 
IL-4 secretion from peripheral blood mono-
nuclear cells (Boskabady et al., 2011) and 
also pro-apoptotic effect of this substance 
in a lung cancer-derived cell line is reported 
(Samarghandian et al., 2010). In addition, 
human studies demonstrated the antidepres-
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sants effects (Akhondzadeh et al., 2005; 
Akhondzadeh Basti et al., 2007) and allevi-
ative role of saffron for women menstrual 
distress (Fukui et al., 2011). Despite the 
beneficial effect of saffron, Mohajeri et al. 
(2007) indicated that high doses of Crocus 
sativus L. stigma is associated with hepato-
toxic and nephrotoxic effects. 
Electrical properties of heart are consid-
ered as an integral part of heart function. 
Impairment of the electrical rhythm and 
electrical conductivity of the heart can lead 
to life-threatening cardiac arrhythmia. 
Annual sudden cardiac death due to 
ventricular arrhythmia has been estimated 
at about six million people (Mehra, 2007). 
In previous study we indicated the cardio-
protective effect of saffron on isopro-
terenol-induced heart injury that partly ap-
plies by improvement of antioxidant system 
(Joukar et al., 2010). Based on best 
knowledge, so far only one in vitro study 
investigated the effect of saffron on heart 
electrical conductivity and reported that saf-
fron has a depressant effect on AV nodal 
rate-dependent properties (Khori et al., 
2012). Considering the global popularity of 
saffron and the discovery of new pharmaco-
logical properties of this spice in recent 
years and also the lack of adequate infor-
mation regarding its effects on cardiac elec-
trophysiology, the present study was de-
signed to investigate the effect of saffron 
extract administration on blood pressure, 
myocardial oxygen demand index (PRP) 
and ECG properties of rat.  
 
MATERIALS AND METHODS 
All experiments were conducted in 
strict concordance with the guidelines of 
animal studies provided by Ethic committee 
permission No 86/123KA—Kerman Uni-
versity of Medical Sciences and performed 
on 30 male Wistar rats weighed 250–300 g, 
purchased from the laboratory animal 
breeding center of medical school, Kerman 
University of Medical Sciences, Kerman, 
Iran.  
 
Preparation of saffron extract 
Saffron stigmas were collected from 
Zarand (Kerman province, Iran), identified 
and confirmed by Botany Department of 
Bahonar, University of Kerman, Iran. Dried 
stigmas were chopped and macerated in tap 
water for 3 days. Then the mixture was fil-
tered and different concentrations of saffron 
solution i.e 50 mg/ml, 100 mg/ml and 
200 mg/ml were prepared separately 
(Joukar et al., 2010). This method was cho-
sen based on the current using pattern 
among consumers. 
 
Animals 
Animals were housed in a temperature-
controlled room and 12-h light/12-h dark 
cycle and were randomized to four groups. 
The control group (CTL) received 1 cc/kg 
of tap water by gastric tube for 7 days. Saf-
fron groups including SAF50, SAF100 and 
SAF200 were fed with saffron extract, the 
similar volume of water used for the control 
group, with doses of 50, 100, and 
200 mg/kg /daily respectively for seven 
days. 
 
Surgical and experimental protocol and 
ECG recording 
On day 8, animals were deeply anesthe-
tized by intraperitoneal injection of sodium 
thiopental (50 mg/kg i.p.) (Joukar et al., 
2011). Animals had spontaneously breath-
ing throughout the experiment. A hepa-
rinized saline filled (15 units/ml) cannula 
inserted into the right carotid artery and 
connected to a pressure transducer and a 
PowerLab analog to digital converter (AD 
Instruments, Australia) for recording of 
heart rate and arterial blood pressure (BP). 
Time window for animal recovery from 
surgery was 15 min. After this time, ECG 
and BP were recorded for analyzing. Mean 
arterial pressure (MAP) was calculated by 
“MAP=Pd+(Ps−Pd)/3 formula”, where Pd 
is the diastolic arterial pressure and Ps is 
the systolic arterial pressure. Pressure-rate 
product (PRP), an indirect measure of myo-
cardial oxygen demand, was determined as 
the product of the heart rate and mean arte-
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rial pressure ((MAP*heart rate)*1000–1) 
(Joukar et al., 2012). The ECG was record-
ed with standard limb lead II using a Pow-
erLab data acquisition system and the dura-
tion and voltage of waves and also intervals 
of ECG were determined by mean of 5 min 
ECG recorded strip. In order to obviate the 
dependence of QT interval on heart rate, 
corrected QT (QTc) intervals were meas-
ured using Bazett's formula normalized as 
QTcn-B=QT/(RR/ f)1/2, where RR is R-R 
interval and f =150 ms (Kmecova and 
Klimas, 2010). 
 
Statistical analysis 
The data are presented as the mean ± 
S.E.M. Comparisons were performed 
among different groups by one-way ANO-
VA and post-hoc Tukey's test. P-values less 
than 0.05 were considered as statistically 
significant. 
 
RESULTS 
Heart rate, arterial blood pressure and 
PRP 
Administration of different doses of saf-
fron for one-week had no significant effect 
on systolic, diastolic, and mean arterial 
pressure and also PRP (Figure 1 and Figure 
2). However the dose of 50 mg/kg/day was 
associated with a significant enhancement 
of the heart rate whenever compared with 
the group of SAF200. A non-significant 
increase of PRP also was observed in 
SAF50 group than other groups (Table 1 
and Figure 2). 
ECG parameters 
Figure 3 shows some sample traces of 
ECGs recorded from different animal 
groups with increased QT intervals in saf-
fron groups along with gradual reduction in 
heart rate at doses higher than 50 mg/kg. 
Trace "a" is from CTL group, trace "b" is 
from SAF50 group, trace "c" is from 
SAF100 group and trace "d" is from 
SAF200 group.  
 
 
Figure 1: Arterial blood pressure in different 
experimental groups. Values are mean ± SEM. 
n=7–8, CTL control, SAF: saffron, S: systolic 
pressure, D: diastolic pressure, MAP: mean 
arterial pressure 
 
 
Figure 2: Pressure – rate product (PRP) as 
mmHg*beats/min*1000–1 in different animal 
groups. SAF: saffron 
 
 
Table 1: ECG parameters of different groups of the study 
GROUP n RR Inter-val (ms) 
Heart 
Rate 
(BPM) 
PR Inter-
val (ms) 
P Duration 
(ms) 
QRS Interval 
(ms) 
QT Inter-
val (ms) QTcn (Ms) 
JT Inter-
val (ms) 
ST 
Height 
(mV) 
T Ampli-
tude (mV) 
CTL 8 150±4.2 394±9 42±0.9 14±1.2 14±0.3 42±1.3 43±1.2 28±1.5 0.03±0.02 0.07±0.03 
SAF50 7 146±0.7 412±2 44±1.2 15.2±2 16±0.6 53.8±1.2* 53.6±2.2** 38.7±2.2* 0.07±0.01 0.11±0.01 
SAF100 8 151±3.9 391±9 44±0.8 14±0.7 16±0.6 58±0.6** 54±2.1*** 43±2.5** 0.03±0.02 0.09±0.01 
SAF200 7 163±4.9▼ 377±9* 47.2±1.3** 18.5±0.9**● 20.1±0.7***●● 54.4±2.8** 54.5±2.4*** 36.8±2.7* 0.02±0.01 0.1±0.01 
n: number of animals, CTL: control, SAF: saffron. Data are presented as mean ± SEM. *p<0.05, 
**p<0.01 and *** P<0.001 versus CTL group,▼p<0.05 versus SAF50 group, ●p<0.01 and ●●p<0.001 
versus SAF50 and SAF100 groups 
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Figure 3: The sample traces of ECG normal sinus rhythm recorded from different animal groups. 
Trace "a" (CTL group), trace "b" (SAF50 group), trace "c" (SAF100) group and trace "d" is from 
SAF200 group 
 
 
As shown in Table 1, the dose of 
200 mg/kg/day of saffron induced more dis-
turbance on ECG than that of other two 
doses (50 and 100 mg/kg/day). Administra-
tion of the higher dose (200 mg/kg) signifi-
cantly increased the PR Interval, P Dura-
tion, QRS Interval, QT Interval, QTcn and 
JT interval of ECG compared to CTL 
group. In addition, lower (50 mg/kg/day) 
and intermediate (100 mg/kg/day) doses of 
saffron only significantly prolonged the QT, 
QTcn and JT intervals of ECG versus CTL 
group. On the other hand, P duration and 
QRS interval were more prolonged in high-
er dose than intermediate and lower doses 
of saffron (p≤0.01 and p≤0.001 respective-
ly) (Table 1). Although the RR interval 
showed a notable increase in SAF200 
group, but it was significant only relative to 
SAF50 group (Table 1 and Figure 3). There 
was no significant difference in the ST 
height and T amplitude ranges of all groups. 
 
DISCUSSION 
The aim of the current study was to elu-
cidate whether saffron consumption has any 
effect on blood pressure, myocardial oxy-
gen demand and electrophysiological con-
duction of rat heart. The results of this ex-
periment indicated that one-week admin-
istration of saffron had no significant effect 
on blood pressure and myocardial oxygen 
demand of normal rat. Saffron apparently 
has no effect on P wave and T wave ampli-
tudes and ST height but especially at higher 
doses significantly slowed the electrical 
conductivity of heart as prolongation of PR 
interval, P duration, QRS interval, QTc in-
terval and JT interval. This means that saf-
fron consumption significantly reduces the 
atrial, nodal and ventricular impulse con-
duction. Previous studies were considered a 
cardiovascular protective role for saffron 
(Sachdeva et al., 2012; Joukar et al., 2010) 
and some of its constituents (Goyal et al., 
2010). Saffron can exert a cardioprotec-
tive effect by preserving hemodynamics 
and left ventricular functions and also at-
tenuation of myocardial degeneration in 
stressful condition (Sachdeva et al., 2012). 
Other study demonstrated the cardioprotec-
tive effect of crocin as a pharmacologically 
active component of saffron in isopro-
terenol-induced cardiac toxicity (Goyal et 
al., 2010). The results of these studies em-
phasized that saffron and crocin can im-
prove the reduction of arterial blood pres-
sure induced by isoproterenol that is con-
sistent with our findings concerning the sta-
bility of blood pressure in the presence of 
saffron. Maintain the normal blood pressure 
along with no significant alteration in heart 
rate in all groups with different doses of 
saffron is a reason to justify the lack of sig-
nificant change in PRP as an index of myo-
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cardial oxygen consumption. The PR inter-
val indicates the atrio-ventricular conduc-
tion velocity pattern. The results showed 
that saffron consumption was associated 
with increase in PR interval that implies 
impairment in atrio-ventricular conduction. 
In agreement with our study, others demon-
strated the depressant effect of saffron on 
AV nodal rate-dependent properties and 
also increasing the Wenckebach block cycle 
length and nodal functional refractory peri-
od in vitro (Khori et al., 2012). Based on 
PR interval prolongation induced by saf-
fron, it is possible that saffron can slow 
nodal conductivity through the blockade of 
calcium current and reduction of the slope 
of pacemaker potential similar to the ac-
tions of class 4 of antiarrhythmic drugs. In 
confirmation of this possibility, it is report-
ed that aqueous-ethanol extract of saffron 
has a potent inhibitory effect on the calcium 
channel of guinea-pig isolated heart (Bos-
kabady et al., 2008). 
The QT interval, the period from QRS 
complex onset to the end of T wave, is con-
sidered as the electrocardiographic manifes-
tation of ventricular depolarization and re-
polarization. Generally, QT interval short-
ens with tachycardia and lengthens with 
bradycardia. For exact assessment of this 
index a rate corrected QT (QTc) should be 
calculated for eliminating its dependence on 
heart rate (Gupta et al., 2007). QTc interval 
increased at different doses of saffron. In-
terestingly, this effect was raised during 
both the depolarization, as the wider QRS 
wave, and repolarization, as the JT interval 
prolongation, phases of action potential. 
This means that similar to atrio-nodal con-
duction, saffron can reduce ventricular con-
duction velocity and also can exert a delay 
on ventricular cells repolarization and 
hence increase action potential duration. 
Myocardial depolarization is mediated by 
influx of sodium ions; however, myocardial 
repolarization primarily is induced by ef-
flux of potassium ions. The QRS prolonga-
tion may result from blockade of sodium 
channels, like to the actions of Class 1 anti-
arrhythmic drugs, and JT interval prolonga-
tion can induce by blockade of potassium 
channel similar to the actions of Class 3 an-
tiarrhythmic drugs (Brunton et al., 2011). 
Therefore, saffron could potentially be an 
antiarrhythmics agent due to its ability for 
reduction of electrical conductivity and also 
for prolongation of action potential. On the 
other hand, long QT interval may cause ear-
ly afterdepolarizations (EADs) due to acti-
vation of inward depolarizing currents. This 
in turn can cause ventricular extrasystoles 
and finally increase the risk of reentry and a 
polymorphic ventricular tachycardia known 
as torsade de pointes (TdP) (Gupta et al., 
2007; Roden et al., 1996). 
In summary, this study showed for the 
first time that oral administration of saffron, 
as commonly used in people, can cause 
changes in the ECG of rat. The alterations 
include prolongation of the P wave, QRS 
complex, PR, QTc and JT intervals. These 
electrophysiological disturbances may be 
due to change in expression or permeability 
of ion channels which are responsible for 
the production and propagation of the ac-
tion potential in cardiac cells. Future studies 
are needed to clarify the exact mechanisms 
as well as long-term consequences of saf-
fron consumption on the electrical charac-
teristics of the human heart. 
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